Peritoneal dialysate IgG/C3 levels do not predict susceptibility to peritonitis

Peritoneal Dialysis International

Volumn 16, Issue 2, 1996, Pages 154-157

  Anwar, Nisar ^a   Hutchison, Alastair J ^a   Manos, John ^a   Uttley, Linda ^a   Brenchley, Paul ^a   Gokal, Ram ^a,b  

^a ST MARY S HOSPITAL   (United Kingdom)

^b MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

C3 complement; IgG; Peritonitis

Indexed keywords

COMPLEMENT COMPONENT C3; IMMUNOGLOBULIN G; OPSONIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; DIALYSATE; FEMALE; HUMAN; MALE; PERITONITIS; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY;

EID: 0029977231     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686089601600212     Document Type: Article

References (19)

1. Jindal KK, Hirsch DJ. Excellent technique survival on home peritoneal dialysis: results of a regional program. Perit Dial Int 1994; 14:324-6.
2. Wilkelstein JA. Opsonins; their function, identity and clinical significance. J Pediatr 1973; 82:747-53.
3. Coles GA. Immunoglobulin and complement. CAPD: host defence, nutrition and ultrafiltration. In: Coles GA, Davies M, Williams JD, eds. Contributions to nephrology, vol. 85. Basel: Karger, 1990:24-9.
4. Verbrugh HA, Keane WF, Hoidal JR, Freiberg MR, Elliot GR, Peterson PK. Peritoneal macrophages and opsonins: antibacterial defence in patients undergoing chronic peritoneal dialysis. J Infect Dis 1983; 147:1018-29.
5. Simberkoff MS, Moldover NH, Weiss G. Bactericidal and opsonic activity of cirrhotic ascites and nonascitic peritoneal fluid. J Lab Clin Med 1978; 91:831-9.
6. Keane WF, Comty CM, Verbrugh HA, Peterson PK Opsonic deficiency of peritoneal dialysis effluent in continuous ambulatory peritoneal dialysis.Kidney Int 1984; 25:539-43.
7. Coles GA, Alobaidi HMM, Topley N, Davies M. Opsonic activity of dialysis effluent predicts those at risk of Staphylococcus epidermidis peritonitis. Nephrol Dial Transplant 1987; 2:359-65.
8. Steen S, Brenchley P, Manos J, Pumphrey P, Gokal R. Opsonizing capacity of peritoneal fluid and relationship to peritonitis in CAPD patients. In: Maher JF, Winchester JF, eds. Frontiers in peritoneal dialysis. New York: Field, Rich and Association, 1986:565-8.
9. Sternberg JC. Rate-nephelometry. In: Rose N, Friedman H, Flahey J, eds. Manual of clinical laboratory immunology. New York: American Society for Microbiology, 1986:330-7.
10. McGregor SJ, Brock JH, Briggs JD, Junor JR. Longitudinal study of peritoneal defence mechanisms in patients on continuous ambulatory peritoneal dialysis (CAPD). Perit Dial Int 1989; 9:115-19.
11. Coles GA, Minors SJ, Horton JK, Fifield R, Davies M. Can the risk of peritonitis be predicted for new continuous ambulatory peritoneal dialysis (CAPD) patients? Perit Dial Int 1989; 9:69-72.
12. Lamperi S, Carrozi S. Defective opsonic activity of peritoneal effluent during continuous ambulatory peritoneal dialysis (CAPD) - importance and prevention. Perit Dial Bull 1986; 6:87-92.
13. 3 and transferrin with opsonizing and bacteriostatic activity of peritoneal fluid from CAPD patients and incidence of peritonitis. Nephrol Dial Transplant 1987; 2:551-6.
14. Bennett-Jones DN, Yewdall YMA, Gillepsie ME, Ogg CS, Cameron JS. Strain differences in the opsonization of Staphylococcus epidermidis. Perit Dial Int 1989; 9:333-9.
15. Keane WF, Peterson WK Host defence mechanisms of peritoneal cavity and continuous ambulatory peritoneal dialysis. Perit Dial Bull 1984; 4:122-7.
16. Keane WF, Bergerson B, Pence T. Challenges for continuous ambulatory peritoneal dialysis. In: Davison AM, ed. Nephrology. Proceedings of the 10th International Congress of Nephrology. London: Bailliere Tindall, 1988; 2:1255-67.
17. Goodship THJ, Mclachlan SM, Poon TFH. Immunoglobulins in CAPD. In: Maher JF, Winchester JF, eds. Frontiers in peritoneal dialysis. New York: Field, Rich and Association, 1986:600-3.
18. Zemel D, Struijk DG, Krediet RT, Koomen GCM, Arisz L. No relationship between dialysate IgG and peritonitis incidence in CAPD (Abstract). Nephrol Dial Transplant 1989; 4:501-2.
19. DeVecci A, Castelnovo C, Failla S, Scalamogna A. Clinical significance of peritoneal IgGin CAPD Nephrol Dial Transplant 1989; 4:496-7.